Issuance was led by a $2 billion retail pricing from the University of California in the negotiated market and a $1.2 billion competitive deal from Washington.

Dyne Therapeutics Inc (DYN) stock saw a modest uptick, ending the day at $14.55 which represents a slight increase of $0.42 or 2.97% from the prior close of $14.13. The stock opened at $14.3 and ...

In a report released yesterday, Deane Dray from RBC Capital maintained a Sell rating on 3M (MMM – Research Report), with a price target of ...

In a report released today, Nik Modi from RBC Capital maintained a Buy rating on Monster Beverage (MNST – Research Report), with a price target ...

Hedge funds have positioned for Donald Trump's U.S. presidency with their highest levels of borrowing since 2010, while ...

Underperforming since the calendar turned, "munis have continued to cheapen over the past three weeks as Treasury returns are about flat for the year while munis are down 0.31%," said Jason Wong, vice ...

RBC Capital Markets adjusted its stance on Intra-Cellular Therapies shares, downgrading the biopharmaceutical company from Outperform to Sector Perform. The firm, however, raised its price target on ...

U.S. stock-trading hedge funds kicked off the week with gross leverage levels in their highest range since 2010.

Morgan Stanley Wealth Management today announced results from its quarterly retail investor pulse survey: Majority of ...

T-Mobile Us Inc (TMUS) stock saw a modest uptick, ending the day at $218.97 which represents a slight increase of $3.22 or 1.49% from the prior close of $215.75. The stock opened at $219.21 and ...

RBC Capital Markets adjusted their outlook on Morgan Stanley (NYSE:MS) shares, raising the price target from $122.00 to ...

Standard Chartered printed a $1bn four year non-call three bond at 105bp over US Treasuries, and a $1bn 11 year non-call 10 ...